Crossmark Global Holdings, Inc. Integra Lifesciences Holdings Corp Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$34.21 - $44.59 $24,939 - $32,506	-729 Reduced 12.02%	5,336 $232,000
Q3 2023 Nov 08, 2023	SELL	$37.8 - $45.97 $8,089 - $9,837	-214 Reduced 3.41%	6,065 $234,000
Q2 2023 Jul 31, 2023	SELL	$37.95 - $58.98 $17,305 - $26,894	-456 Reduced 6.77%	6,279 $285,000
Q1 2023 May 12, 2023	BUY	$52.61 - $60.49 $526 - $604	10 Added 0.15%	6,735 $387,000
Q4 2022 Jan 19, 2023	SELL	$42.17 - $58.6 $18,006 - $25,022	-427 Reduced 5.97%	6,725 $377,000
Q3 2022 Nov 01, 2022	SELL	$42.28 - $57.17 $4,228 - $5,717	-100 Reduced 1.38%	7,152 $303,000
Q2 2022 Jul 29, 2022	SELL	$53.86 - $66.52 $13,465 - $16,630	-250 Reduced 3.33%	7,252 $392,000
Q1 2022 May 11, 2022	BUY	$62.86 - $69.24 $11,943 - $13,155	190 Added 2.6%	7,502 $482,000
Q4 2021 Jan 10, 2022	BUY	$62.47 - $73.25 $48,726 - $57,135	780 Added 11.94%	7,312 $490,000
Q3 2021 Oct 21, 2021	BUY	$64.97 - $76.19 $424,384 - $497,673	6,532 New	6,532 $447,000
Q3 2021 Oct 13, 2021	SELL	$64.97 - $76.19 $423,084 - $496,149	-6,512 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$66.79 - $76.63 $22,040 - $25,287	330 Added 5.34%	6,512 $444,000
Q4 2020 Jan 14, 2021	SELL	$43.31 - $66.55 $7,795 - $11,979	-180 Reduced 2.83%	6,182 $401,000
Q3 2020 Oct 08, 2020	SELL	$43.33 - $51.72 $866 - $1,034	-20 Reduced 0.31%	6,362 $300,000
Q2 2020 Aug 14, 2020	SELL	$41.42 - $55.57 $1,988 - $2,667	-48 Reduced 0.75%	6,382 $300,000
Q1 2020 Apr 28, 2020	SELL	$36.67 - $61.04 $1,100 - $1,831	-30 Reduced 0.46%	6,430 $287,000
Q4 2019 Feb 06, 2020	SELL	$55.73 - $62.49 $126,507 - $141,852	-2,270 Reduced 26.0%	6,460 $376,000
Q3 2019 Oct 09, 2019	SELL	$53.29 - $64.59 $24,513 - $29,711	-460 Reduced 5.01%	8,730 $524,000
Q2 2019 Jul 09, 2019	SELL	$46.45 - $55.85 $9,754 - $11,728	-210 Reduced 2.23%	9,190 $513,000
Q1 2019 May 02, 2019	BUY	$42.97 - $57.33 $2,578 - $3,439	60 Added 0.64%	9,400 $524,000
Q4 2018 Jan 31, 2019	BUY	$42.62 - $64.51 $84,813 - $128,374	1,990 Added 27.07%	9,340 $421,000
Q3 2018 Nov 08, 2018	BUY	$57.63 - $65.87 $4,034 - $4,610	70 Added 0.96%	7,350 $484,000
Q2 2018 Jul 31, 2018	SELL	$54.05 - $67.23 $142,151 - $176,814	-2,630 Reduced 26.54%	7,280 $469,000
Q1 2018 Apr 16, 2018	SELL	$46.55 - $57.38 $117,306 - $144,597	-2,520 Reduced 20.27%	9,910 $548,000
Q4 2017 Feb 05, 2018	BUY	$46.22 - $51.77 $7,395 - $8,283	160 Added 1.3%	12,430 $595,000
Q3 2016 Oct 25, 2017	BUY	N/A	12,270	12,270 $619,000

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$249 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$172 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$116 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$93.4 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$87.9 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account